Maria T. Pintos-Abalde

Islabekoa, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Safety Profile of Systemic Therapy for the Management of Psoriasis in Patients With Diabetes Mellitus: Data From the BIOBADADERM Prospective Cohort.

Safety Profile of Systemic Therapy for the Management of Psoriasis in Patients With Diabetes Mellitus: Data From the BIOBADADERM Prospective Cohort.

Journal: Actas dermo-sifiliograficas

Published: December 31, 2025

Risk of infections in patients with psoriasis treated with biologic agents and new oral small molecules: BIOBADADERM registry.

Risk of infections in patients with psoriasis treated with biologic agents and new oral small molecules: BIOBADADERM registry.

Journal: The Journal of investigative dermatology

Published: June 18, 2025

Real-world use of anifrolumab in refractory cutaneous lupus: case series and review of the literature.

Real-world use of anifrolumab in refractory cutaneous lupus: case series and review of the literature.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: May 09, 2025

Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry.

Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 13, 2024

Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry.

Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 21, 2024

Survival of Interleukin-17 and Interleukin-23 Inhibitors in Patients Previously Treated With a Tumor Necrosis Factor Inhibitor: Analysis of the Spanish Biobadaderm Registry.

Survival of Interleukin-17 and Interleukin-23 Inhibitors in Patients Previously Treated With a Tumor Necrosis Factor Inhibitor: Analysis of the Spanish Biobadaderm Registry.

Journal: Actas dermo-sifiliograficas

Published: May 15, 2024

Topical and Intralesional Immunotherapy for the Management of Basal Cell Carcinoma.

Topical and Intralesional Immunotherapy for the Management of Basal Cell Carcinoma.

Journal: Cancers

Published: April 29, 2024

Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.

Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.

Journal: The British journal of dermatology

Published: May 24, 2023

[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

Journal: Actas dermo-sifiliograficas

Published: May 02, 2023

Plantar Reconstruction Using a Dermal Substitute: Description of 2 Cases.

Plantar Reconstruction Using a Dermal Substitute: Description of 2 Cases.

Journal: The international journal of lower extremity wounds

Published: June 26, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026